PreciseDx Raises $10.75 Million Series A Preferred from Healthcare Industry Leaders to Commercialize Cancer Risk Stratification Services to Support Better Patient Insights and Outcomes

Join our newsletter

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

OncoIntelligenceTM

Navigation
Why PreciseDxPreciseBreastResourcesAbout Us
Who We Serve
For OncologistsFor Breast SurgeonsFor PathologistsFor PayorsFor Patients

810 7th Ave, Suite 515, New York NY 10019

 |  

2645 Southwest 37th Ave. Coral Gables, FL. 33133

Privacy PolicyNotice of Privacy PracticesConsumer Health Data Privacy Policy